All News
Tech Xplore / A safety report card ranks AI company efforts to protect humanity
Are artificial intelligence companies keeping humanity safe from AI's potential harms? Don't bet on it, a new report card says.
Medical Xpress / Anti-platelet drug can slow metastasis in aggressive cancers, research shows
Aggressive cancers can use blood vessels like roadways, speeding through the body and finding new places to grow. But new research shows that a drug in clinical trials may help stop the spread of cancer before it reaches ...
Medical Xpress / Examining impact of federal relief program after major health care cyberattack
New research from the University of Minnesota School of Public Health provides the first detailed look at whether funding provided through a federal relief program effectively reached hospitals affected by a ransomware attack ...
Tech Xplore / Setting the standard for more durable concrete
As infrastructure ages, one question shapes the future of cities: How do we know the materials we build with will last?
Medical Xpress / Opioid use linked to higher risk of C. difficile infection
New research from the University of Georgia suggests that opioid use could make patients more vulnerable to infections.
Medical Xpress / Aza–ven combination outperforms standard care in AML patients eligible for intensive chemotherapy
In a new trial, patients newly diagnosed with acute myeloid leukemia (AML) fared significantly better with a combined regimen of azacitidine and venetoclax compared with conventional induction chemotherapy. The azacitidine–venetoclax ...
Medical Xpress / New findings support a chemo-free approach for treating Ph+ ALL
A chemotherapy-free combination treatment outperformed a combination of targeted therapy and chemotherapy among patients with Ph+ acute lymphoblastic leukemia (ALL) in a new study. The Phase III trial, which included adult ...
Medical Xpress / Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes
In a new trial, patients with follicular lymphoma had a significantly higher response to treatment and a nearly 80% reduction in the risk of death or disease progression if they received epcoritamab in addition to the standard ...
Phys.org / Hayli Gubbi's explosive first impression
On November 23, 2025, the Hayli Gubbi volcano in northern Ethiopia erupted in dramatic fashion. The shield volcano in the Danakil (or Afar) Depression began spewing ash and volcanic gases at around 11:30 a.m. local time (8:30 ...
Medical Xpress / Telling people to use antibiotics responsibly isn't enough. What will work instead?
Antimicrobial resistance is projected to cause up to 10 million deaths each year by 2050, making it one of the most pressing global health challenges of this century. In 2021, an estimated 4.71 million deaths were associated ...
Medical Xpress / Black patients with AML are younger at diagnosis, experience poorer survival outcomes than white patients, data show
Compared with white patients, Black patients with acute myeloid leukemia (AML) were on average more than five years younger at diagnosis, more than 30% more likely to die of their disease, and more than 20% more likely to ...
Phys.org / A sound defense: Noisy pupae puff away potential predators
Insect pupae hiss like snakes for defense. A Kobe University team now reveals the mechanisms, opening the door to further studies involving predator reactions to defensive sounds.
